Now showing items 81-90 of 122
The epidemiology and natural history of Crohn’s disease in population-based patient cohorts from North America: a systematic review
(Blackwell Science Ltd, 2002-01-07)
To quantify, through systematic review, the epidemiology and natural history of Crohn’s disease in North America. Methods: The selected articles contained: (i) population-based samples of patients followed from the time ...
Effect of cyclooxygenase-2 inhibition on human Helicobacter pylori gastritis: mechanisms underlying gastrointestinal safety and implications for cancer chemoprevention
(Blackwell Science Ltd, 2003-06)
Cyclooxygenase (COX)-2 expression and prostaglandin production is increased by Helicobacter pylori infection. Non-selective COX inhibitors reduce prostaglandins and mucosal proliferation in infected mucosa and may reduce ...
Cost‐effectiveness analysis: cardiovascular benefits of proton pump inhibitor co‐therapy in patients using aspirin for secondary prevention
(Blackwell Publishing LtdWiley Periodicals, Inc., 2011-07)
Characterizing abdominal pain in IBS: guidance for study inclusion criteria, outcome measurement and clinical practice
(Blackwell Publishing Ltd, 2010-11)
Aliment Pharmacol Ther 2010; 32: 1192–1202Although irritable bowel syndrome (IBS) is a multisymptom disorder, abdominal pain drives illness severity more than other symptoms. Despite consensus that IBS trials should ...
Haemoglobin decreases in NSAID users over time: an analysis of two large outcome trials
(Blackwell Publishing LtdWiley Periodicals, Inc., 2011-10)
The effect of mesalazine therapy on quality of life in patients with mildly and moderately active ulcerative colitis
(Blackwell Publishing Ltd, 2008-12)
Systematic review: cardiovascular safety profile of 5‐ HT 4 agonists developed for gastrointestinal disorders
(Wiley Periodicals, Inc., 2012-04)
Safety and tolerability of rifaximin for the treatment of irritable bowel syndrome without constipation: a pooled analysis of randomised, double‐blind, placebo‐controlled trials
(Wiley Periodicals, Inc.Salix Pharmaceuticals, Inc., 2014-05)
Editorial: ultrasound surveillance of hepatocellular carcinoma in the 21st century – authors’ reply
(Wiley Periodicals, Inc., 2017-02)